Virginia Commonwealth University

VCU Massey Cancer Center

New protein discovered with vast potential for treatment of cancer and other diseases

Chalfant for blog post

In cancer research, discovering a new protein that plays a role in cancer is like finding a key and a treasure map: follow the clues and eventually there could be a big reward. At least that’s the hope from a new study published in the journal Nature that discovered a novel protein called ceramide-1 phosphate transport protein (CPTP) – a finding that could eventually lead to the development of new drugs to treat a variety of cancers and other conditions involving inflammation and thrombosis, or blood clotting.

Continue reading →

Massey’s bone marrow transplant unit receives Beacon Award for Excellence

Beacon Award of Excellent for blog post

The inpatient bone marrow transplant (BMT) unit at VCU Massey Cancer Center is the first of its kind in the nation to earn the American Association of Critical-Care Nurses (AACN) Beacon Award for Excellence.  A BMT is a procedure that replaces damaged or destroyed bone marrow with healthy bone marrow stem cells in the treatment of blood cancers like leukemia and lymphoma and other blood and immune disorders. The AACN Beacon Award for Excellence recognizes individual units that distinguish themselves by improving every facet of patient care.

Continue reading →

Novel gene target shows promise for bladder cancer detection and treatment

Fisher and Dasgupta for blog post

Scientists from Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression. The study, published in the journal Clinical Cancer Research, was a collaborative effort between Paul B. Fisher, M.Ph., Ph.D., who originally discovered the mda-9/syntenin gene, and Santanu Dasgupta, Ph.D., an expert in bladder cancer research.

Continue reading →

Massey rated the top cancer center in Virginia by U.S. News two years in a row

U.S. News logo for blog

For the second year in a row, Virginia Commonwealth University Massey Cancer Center was rated the top hospital in Virginia providing high-performing cancer care in U.S. News & World Report’s annual Best Hospitals list. Massey received the highest score in cancer care of the 20 Virginia cancer providers that made the list. VCU Medical Center, which includes Massey’s oncology patient care, also established itself as a No. 1 hospital overall in Virginia for a second consecutive year. It saw two specialty areas rank in the top 50 in the nation, nephrology at 41 and orthopedics in the No. 39 spot.

Continue reading →

New Massey Research Pavilion fosters collaboration among cancer researchers

McLoughlin

A new hub for cancer research known as the Massey Research Pavilion opened in April 2013 in the VCU School of Medicine’s McGlothlin Medical Education Center, a new 12-story, 200,000-square-foot, state-of-the-art building. The Massey Research Pavilion—located on floors 11 and 12—provides 27,000-square-feet of dedicated space for VCU Massey Cancer Center’s clinical trials research, cancer prevention and control research and Division of Hematology, Oncology and Palliative Care chair, Steven Grossman, M.D., Ph.D., and his administrators. Each floor is appointed with a suite of research offices and conference rooms.

Continue reading →